FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA granted supplemental approval for Ampicillin and Sulbactam (AMPICILLIN AND SULBACTAM) submitted by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Infection
• Intra-abdominal Infection
• Lower Respiratory Tract Infection
• Skin and Skin Structure Infection

Drugs mentioned

• AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)

Snippet

SUPPL AP for AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)